Biotech Nektar Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference March 22, 2025
Biotech Antengene Announces 2024 Full-Year Financial Results, Proprietary Programs Advancing to Pivotal Trials with Accelerating Multi-market Revenue Ramp Up March 21, 2025
Biotech Multiple Myeloma Market to Witness Substantial Growth — Key Trends and Forecasts of Different Reports for the Next Decade | DelveInsight March 20, 2025
Biotech Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics March 18, 2025
Biotech Skyhawk Therapeutics Presents at Huntington’s Disease Youth Organization HDYO International Congress 2025 March 17, 2025
Biotech iOncologi, Inc. Acquires TargImmune Therapeutics to Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors March 16, 2025
Biotech BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors March 14, 2025